A model‐based analysis to guide gonadotropin‐releasing hormone receptor antagonist use for management of endometriosis

por Pohl, Oliver, Baron, Kyle, Riggs, Matthew, French, Jonathan, Garcia, Ramon, Gotteland, Jean‐Pierre
Publicado 2022

Confirmation of the Cardiac Safety of PGF(2α) Receptor Antagonist OBE022 in a First‐in‐Human Study in Healthy Subjects, Using Intensive ECG Assessments

por Täubel, Jörg, Lorch, Ulrike, Coates, Simon, Fernandes, Sara, Foley, Paul, Ferber, Georg, Gotteland, Jean‐Pierre, Pohl, Oliver
Publicado 2018

Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium

por Kim, Sung Hye, Pohl, Oliver, Chollet, Andre, Gotteland, Jean-Pierre, Fairhurst, Adam D. J., Bennett, Phillip R., Terzidou, Vasso
Publicado 2017

Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F(2α)-induced Contractions and Inflammatory Responses in Human Myometrium

por Kim, Sung Hye, Riaposova, Lucia, Ahmed, Hauwa, Pohl, Oliver, Chollet, André, Gotteland, Jean-Pierre, Hanyaloglu, Aylin, Bennett, Phillip R., Terzidou, Vasso
Publicado 2019

Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers

por Täubel, Jörg, Lorch, Ulrike, Spencer, Christopher S., Freier, Anne, Camilleri, Dorothée, Djumanov, Dilshat, Ferber, Georg, Marchand, Line, Gotteland, Jean-Pierre, Pohl, Oliver
Publicado 2021